What is the treatment for acute interstitial nephritis (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) induced kidney inflammation)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acute Interstitial Nephritis (NSAID-induced)

The primary treatment for NSAID-induced acute interstitial nephritis is immediate discontinuation of the offending agent, followed by corticosteroid therapy initiated within 7 days of diagnosis to improve recovery and decrease the risk of chronic renal impairment. 1

Diagnostic Approach

  • Assess temporal relationship between NSAID administration and AKI onset
  • Evaluate urinalysis findings:
    • Pyuria, hematuria, white cell casts, and possible eosinophiluria
    • Fractional excretion of urea (FEUrea) <28% (sensitivity 75%, specificity 83%)
  • Consider renal biopsy for definitive diagnosis, especially in severe or atypical cases
  • Kidney biopsy will show interstitial inflammation, tubulitis, and edema 2

Treatment Algorithm

Step 1: Immediate Management

  • Discontinue the causative NSAID immediately 2
  • This is the most critical intervention as continued exposure significantly worsens outcomes
  • Avoid all nephrotoxic medications during recovery 3

Step 2: Corticosteroid Therapy

Based on severity of renal dysfunction:

Grade Treatment
Mild (Grade 1) Monitor creatinine weekly
Moderate (Grade 2) Prednisone 0.5-1 mg/kg/day orally, taper over 4-6 weeks if improved
Severe (Grade 3-4) Methylprednisolone 1-2 mg/kg/day IV; consider pulse methylprednisolone in severe cases; taper over at least 4 weeks once improved [1]

Step 3: Supportive Care

  • Maintain euvolemia
  • Adjust medication dosages based on renal function
  • Monitor for electrolyte imbalances
  • Consider renal replacement therapy for:
    • Hyperkalemia
    • Refractory acidosis
    • Volume overload
    • Uremic symptoms 1

Step 4: Advanced Therapy for Refractory Cases

  • If no improvement after 3-5 days of corticosteroid therapy, consider additional immunosuppression:
    • Infliximab
    • Azathioprine
    • Cyclophosphamide
    • Cyclosporine
    • Mycophenolate mofetil 1, 4

Important Considerations

Timing of Treatment

  • Early administration of corticosteroids (within 7 days of diagnosis) is associated with better outcomes 1
  • Delayed treatment significantly increases risk of progression to chronic kidney disease 2

Risk Factors for Progression to Chronic Disease

  • Prolonged NSAID use (>1 month) prior to diagnosis increases risk of permanent renal insufficiency by 88% 5
  • Presence of interstitial granulomas on biopsy (found in 31% of cases with permanent damage) 5
  • Tubular atrophy on histology 5

Prevention of Recurrence

  • Avoid re-exposure to the causative NSAID and all other NSAIDs due to high risk of recurrence 1
  • Educate patients to avoid taking NSAIDs or any new medications without consulting their nephrologist 3
  • Use ACE inhibitors, decongestants, antivirals, antibiotics, and herbal products with caution during recovery 3

Prognosis

  • NSAID-induced AIN has a 56% risk of causing permanent renal insufficiency if not properly managed 5
  • Early recognition and discontinuation of the offending agent significantly improves outcomes
  • Patients should be monitored for development of chronic kidney disease following AIN 2

Pitfalls to Avoid

  • Misdiagnosing as other forms of AKI (check for allergic manifestations and eosinophiluria)
  • Continuing NSAID therapy during evaluation (discontinue immediately upon suspicion)
  • Delaying corticosteroid therapy (initiate within 7 days for best outcomes)
  • Using the "triple whammy" combination of NSAIDs, diuretics, and ACE inhibitors/ARBs during recovery 3
  • Restarting NSAIDs after recovery (high risk of recurrence)

References

Guideline

Acute Kidney Injury Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug-induced acute interstitial nephritis.

Nature reviews. Nephrology, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.